Eun J. Yeo
Chuncheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
RETRACTED: Choi et al. PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease. Molecules 2021, 26, 3329.
Journal: Molecules (Basel, Switzerland)
Published: July 07, 2026
Tat-GSTpi suppresses inflammatory responses by regulating ROS/MAPKs/apoptosis signaling pathways.
Journal: BMB reports
Published: June 11, 2025
Tat-RAN attenuates brain ischemic injury in hippocampal HT-22 cells and ischemia animal model.
Journal: Neurochemistry international
Published: February 16, 2023
Tat-GSTpi Inhibits Dopaminergic Cells against MPP+-Induced Cellular Damage via the Reduction of Oxidative Stress and MAPK Activation.
Journal: Biomedicines
Published: February 15, 2023
Protective Effects of PEP-1-GSTA2 Protein in Hippocampal Neuronal Cell Damage Induced by Oxidative Stress.
Journal: International journal of molecular sciences
Published: December 21, 2022
Utilization of an Intracellular Calcium Mobilization Assay for the Screening of Transduced FK506-Binding Proteins.
Journal: Assay and drug development technologies
Published: August 20, 2021
RETRACTED: PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease.
Journal: Molecules (Basel, Switzerland)
Published: May 12, 2021
Transduced Tat-PRAS40 prevents dopaminergic neuronal cell death through ROS inhibition and interaction with 14-3-3σ protein.
Journal: Free radical biology & medicine
Published: February 01, 2021
Last Updated: 09/26/2026